Global and Region Granulocyte Macrophage Colony Stimulating Factor Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Granulocyte Macrophage Colony Stimulating Factor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Granulocyte Macrophage Colony Stimulating Factormarket, defines the market attractiveness level of Granulocyte Macrophage Colony Stimulating Factor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Granulocyte Macrophage Colony Stimulating Factor industry, describes the types of Granulocyte Macrophage Colony Stimulating Factor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Granulocyte Macrophage Colony Stimulating Factor market and the development prospects and opportunities of Granulocyte Macrophage Colony Stimulating Factor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Granulocyte Macrophage Colony Stimulating Factor market in Chapter 13.

    By Player:

    • Takeda Pharmaceutical Co Ltd

    • Cold Genesys Inc

    • GlaxoSmithKline Plc

    • Aduro BioTech Inc

    • Morphotek Inc

    • Amgen Inc

    • Humanigen Inc

    • Sillajen Biotherapeutics

    • BriaCell Therapeutics Corp

    • Mologen AG

    By Type:

    • CG-0070

    • Gimsilumab

    • GSK-3196165

    • Lenzilumab

    • MGN-1601

    • Others

    By End-User:

    • Solid Tumor

    • Lymphoma

    • Kidney Cancer

    • Lung Disease

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Granulocyte Macrophage Colony Stimulating Factor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Granulocyte Macrophage Colony Stimulating Factor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Granulocyte Macrophage Colony Stimulating Factor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Granulocyte Macrophage Colony Stimulating Factor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Outlook to 2022

    • 7.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.2 United States Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.3 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.4 China Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.5 Japan Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.6 India Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    • 7.7 South Korea Granulocyte Macrophage Colony Stimulating Factor Consumption (2017-2022)

    8 Region and Country-wise Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Outlook to 2028

    • 8.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.2 United States Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.3 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.4 China Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.5 Japan Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.6 India Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.7 South Korea Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast (2022-2028)

    9 Global Granulocyte Macrophage Colony Stimulating Factor Market Outlook by Types and Applications to 2022

    • 9.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CG-0070 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gimsilumab Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global GSK-3196165 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Lenzilumab Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global MGN-1601 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Solid Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Kidney Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Lung Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Granulocyte Macrophage Colony Stimulating Factor Market Outlook by Types and Applications to 2028

    • 10.1 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CG-0070 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gimsilumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global GSK-3196165 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Lenzilumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global MGN-1601 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Lung Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Granulocyte Macrophage Colony Stimulating Factor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Granulocyte Macrophage Colony Stimulating Factor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Granulocyte Macrophage Colony Stimulating Factor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Granulocyte Macrophage Colony Stimulating Factor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Granulocyte Macrophage Colony Stimulating Factor Market Competitive Analysis

    • 14.1 Takeda Pharmaceutical Co Ltd

      • 14.1.1 Takeda Pharmaceutical Co Ltd Company Details

      • 14.1.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.2 Cold Genesys Inc

      • 14.2.1 Cold Genesys Inc Company Details

      • 14.2.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.3 GlaxoSmithKline Plc

      • 14.3.1 GlaxoSmithKline Plc Company Details

      • 14.3.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.4 Aduro BioTech Inc

      • 14.4.1 Aduro BioTech Inc Company Details

      • 14.4.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.5 Morphotek Inc

      • 14.5.1 Morphotek Inc Company Details

      • 14.5.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.6 Amgen Inc

      • 14.6.1 Amgen Inc Company Details

      • 14.6.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.7 Humanigen Inc

      • 14.7.1 Humanigen Inc Company Details

      • 14.7.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.8 Sillajen Biotherapeutics

      • 14.8.1 Sillajen Biotherapeutics Company Details

      • 14.8.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.9 BriaCell Therapeutics Corp

      • 14.9.1 BriaCell Therapeutics Corp Company Details

      • 14.9.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • 14.10 Mologen AG

      • 14.10.1 Mologen AG Company Details

      • 14.10.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Granulocyte Macrophage Colony Stimulating Factor

    • Figure Granulocyte Macrophage Colony Stimulating Factor Picture

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption by Country (2017-2022)

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast by Country (2022-2028)

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CG-0070 Consumption and Growth Rate (2017-2022)

    • Figure Global Gimsilumab Consumption and Growth Rate (2017-2022)

    • Figure Global GSK-3196165 Consumption and Growth Rate (2017-2022)

    • Figure Global Lenzilumab Consumption and Growth Rate (2017-2022)

    • Figure Global MGN-1601 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CG-0070 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gimsilumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GSK-3196165 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lenzilumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MGN-1601 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Export by Region (Top 5 Countries) (2017-2028)

    • Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Cold Genesys Inc (Foundation Year, Company Profile and etc.)

    • Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Aduro BioTech Inc (Foundation Year, Company Profile and etc.)

    • Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Morphotek Inc (Foundation Year, Company Profile and etc.)

    • Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Humanigen Inc (Foundation Year, Company Profile and etc.)

    • Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Sillajen Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table BriaCell Therapeutics Corp (Foundation Year, Company Profile and etc.)

    • Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product and Service

    • Table Mologen AG (Foundation Year, Company Profile and etc.)

    • Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.